Purchase Order 75N98022P00665

<p>The National Cancer Institute, a civilian federal agency, awarded a firm-fixed-price purchase order contract worth $14,500.00 to Labcorp Genetics Inc. for genetic testing services. The contract has an ultimate completion date of October 31, 2025 and was awarded on April 30, 2025. This contract award is not associated with a larger contract vehicle and does not have a set-aside designation.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order to the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, for the NCI Patterns of Care Study focused on prostate cancer, ovarian cancer, and small intestine cancer diagnosed in 2021. The $104,718 contract runs from May 1, 2024 through April 30, 2025 and does not have a set-aside designation. The study aims to describe the...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $26,926 purchase order to Q Squared Solutions Expression Analysis LLC for oncogene sequencing assay services. Under this firm fixed price contract, Expression Analysis will provide sequencing of cancer-related genes to support research at the NIH Clinical Center in Bethesda, Maryland through September 30, 2023. No major subcontractors or set aside designations were identified. This purchase...

The National Cancer Institute (NCI) awarded a $142,009.29 firm fixed-price purchase order contract to Fundacio Centre De Regulacio Genomica, a non-profit biomedical research institute, to perform targeted gene sequencing on samples collected by NCI's Division of Cancer Epidemiology and Genetics. This contract, which does not have a set-aside designation, is expected to be completed by June 2023. The contract was awarded in September 2021 under simplified acquisition procedures for commercial...

This is a $24,000.00 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business located in Lake Forest, California. The contract is for hematology panel services, specifically the sequencing of somatic mutations in bone marrow samples to provide guidance in the treatment and diagnosis of disease. The contract has...

This is a $24,000.00 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a small disadvantaged business. The contract is for providing a hematology panel to perform sequencing of somatic mutations in bone marrow samples, which will provide guidance in the treatment and diagnosis of disease. The contract has an ultimate completion date of December 30,...

This contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance), a non-profit medical research organization. The contract, valued at $109,264.00, is for the National Cancer Institute's Patterns of Care Study to collect data on diagnosis year 2020 breast and colorectal cancer cases, including the use of biomarker tests, targeted therapies, adjuvant...

The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a firm fixed price purchase order valued at forty-seven thousand two hundred forty-two dollars and six cents ($47,242.06) to Metabolon, Inc. to measure metabolomic and lipidomic concentrations on fifty-eight incident pancreatic cancer cases and fifty-eight controls, along with six blinded replicate quality control samples, totaling one hundred twenty-two...

This firm-fixed-price purchase order for $302,039.20 was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to BostonGene Corporation. The contract is for targeted deep sequencing and bioinformatics analysis of 162 human plasma samples to support a clinical trial investigating the safety and efficacy of the Copanlisib/Rituximab combination treatment for previously untreated follicular lymphoma patients. The objective is to obtain plasma...

This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Personal Genome Diagnostics Inc., a for-profit company that provides molecular tissue testing services to federal agencies. The contract, valued at $147,900.00, requires the contractor to provide enhanced analysis of clinical and specimen-derived data on all cancer patients seen at VA network hospitals. The contractor shall furnish solutions for analyzing tissue samples obtained during clinical care...